GOLDMAN SACHS GROUP INC - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 44 filers reported holding DESIGN THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,049,016
-62.8%
444,498
-0.7%
0.00%
-100.0%
Q2 2023$2,818,721
+62.5%
447,416
+48.8%
0.00%
Q1 2023$1,734,601
-38.4%
300,624
+9.5%
0.00%
-100.0%
Q4 2022$2,816,073
-83.0%
274,471
-72.4%
0.00%
-75.0%
Q3 2022$16,614,000
+1201.0%
993,645
+989.1%
0.00%
Q2 2022$1,277,000
-32.5%
91,237
-22.1%
0.00%
Q1 2022$1,892,000
+30.3%
117,132
+72.7%
0.00%
Q4 2021$1,452,000
+79.3%
67,838
+23.0%
0.00%
Q3 2021$810,000
+93.3%
55,134
+161.6%
0.00%
Q2 2021$419,000
-83.2%
21,078
-74.7%
0.00%
-100.0%
Q1 2021$2,495,00083,4500.00%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,526,476$15,402,4837.89%
Logos Global Management LP 5,032,501$11,876,7021.58%
Prosight Management, LP 1,203,745$2,840,8380.90%
TANG CAPITAL MANAGEMENT LLC 1,350,000$3,186,0000.45%
Soleus Capital Management, L.P. 1,025,000$2,419,0000.22%
RTW INVESTMENTS, LP 2,512,986$5,930,6470.12%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 180,000$425,0000.09%
Corton Capital Inc. 27,134$64,0360.03%
OCCUDO QUANTITATIVE STRATEGIES LP 100,722$237,7040.03%
Rock Springs Capital Management LP 460,391$1,086,5230.03%
View complete list of DESIGN THERAPEUTICS INC shareholders